.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Daiichi Sankyo
QuintilesIMS
Fish and Richardson
Cantor Fitzgerald
Colorcon
Baxter
Healthtrust
Dow

Generated: January 20, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Japan Patent: 2000-354959

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
CerexaTEFLAROceftaroline fosamilPOWDER;IV (INFUSION)200327-001Oct 29, 2010RXYesNo➤ Subscribe➤ SubscribeY
CerexaTEFLAROceftaroline fosamilPOWDER;IV (INFUSION)200327-002Oct 29, 2010RXYesYes➤ Subscribe➤ SubscribeY
CerexaTEFLAROceftaroline fosamilPOWDER;IV (INFUSION)200327-001Oct 29, 2010RXYesNo➤ Subscribe➤ SubscribeYY
CerexaTEFLAROceftaroline fosamilPOWDER;IV (INFUSION)200327-002Oct 29, 2010RXYesYes➤ Subscribe➤ SubscribeYY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist